Clearwater Paper Corporation · NYSE:CLW

Clearwater Paper — Investor Presentation (May 2017)

46 slides from Clearwater Paper's investor presentation, May 17, 2017

  1. Slide 1: Clearwater Paper Corporation May 2017

    Clearwater Paper Corporation May 2017 Exhibit 99.1

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements This supplemental information contains, in addition to historical information, certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding, North American tissue demand and capacity, private

  3. Slide 3: Overview of Clearwater Paper

    Overview of Clearwater Paper

  4. Slide 4: Introduction to Clearwater Paper

    INTRODUCTION TO CLEARWATER PAPER We are a company formed in late 2008 with more than 60 years of operating history We operate two business segments Pulp and paperboard: 43% of 2016 net sales Consumer products: 57% of 2016 net sales Financial overview for 2016 Net Sales: $1.7 Billion Adjusted EBITDA1

  5. Slide 5: Consumer Products Division Overview

    Consumer Products Division Overview Clearwater Paper is one of the LARGEST NORTH AMERICAN MANUFACTURERS OF PRIVATE LABEL TISSUE, focused on high value tissue products across all categories, retail channels and geographies.

  6. Slide 6: Consumer Products Division market drivers

    Consumer Products Division market drivers STABLE GROWTH – The tissue market has grown an average of 1% − 2% annually since 1996, consistent with population growth. U.S. Tissue Demand (Indexed) U.S. Population (mm) Source: RISI estimates as of December 2016, U.S. Population per U.S. Census December 2

  7. Slide 7: Consumer Products Division capacity and retail channels

    Consumer Products Division capacity and retail channels Overview of Facilities Tissue Production Capacity1: 413,000 tons Tissue Conversion Capacity1: 370,000 tons ● Clearwater Paper Tissue Parent Roll ● Clearwater Paper Tissue Converting 1 Annual capacity is an estimate based on assumptions and judg

  8. Slide 8: Private label continues to capture market share in tissue

    private label continues to capture market share in tissue Clearwater Paper ranks as one of the LARGEST NORTH AMERICAN PRIVATE LABEL TISSUE MANUFACTURERS Private Label Market Share of Total U.S. ($) 2016 U.S. Retail Tissue Industry Product Mix 2016 Bath Tissue 54% Paper Towels 32% Facial Tissue 10% N

  9. Slide 9: Opportunity for private label and Clearwater Paper to grow market share nationally

    Opportunity for private label and clearwater paper to grow market share NATIONALLY Clearwater Paper Market Share by Region ($)1 WEST MID-WEST EAST Clearwater Paper 16.7% 7.1% 4.6% Brand Names 72.2% 75.7% 76.4% Other Private Label 11.1% 17.2% 19.0% 1 Market share for 2014-2016 was calculated using IR

  10. Slide 10: North American market demand vs. capacity

    north american market demand vs. capacity Longer Term Market Expected to Remain in Equilibrium Source: RISI August 2016 update for Outlook for World Tissue Business, RISI April 2017 US Tissue Monthly Data 1 It is assumed that any productivity improvements (approximately 100k per year or 1% of capaci

  11. Slide 11: Paperboard Division Overview

    PaPERBOARD Division Overview LEADING MANUFACTURER OF SBS1 used in packaging of premium consumer goods, pharmaceuticals, food and liquid, and food service plates, cups and folding cartons. 1 Solid Bleach Sulfate paperboard

  12. Slide 12: Paperboard demand expected to remain stable

    PAPERBOARD DEMAND expected to REMAIN STABLE U.S. Bleached Paperboard total production (Indexed)1 Source: RISI estimates as of December 2016 ¹ Actual and estimated production was obtained from RISI – Total tons bleached paperboard produced in US ² Average price per short ton of 16 pt. SBS folding car

  13. Slide 13: Pulp and paperboard division capacity and markets

    Pulp and paperboard division capacity and markets Clearwater Paper ranks as one of the top five largest paperboard manufacturers in North America ● Clearwater Paper Pulp ● Clearwater Paper SBS ● Manchester SBS Sheeting Overview of Facilities Pulp Production Capacity1: 857,000 tons Paperboard Product

  14. Slide 14: Our Macro Strategy to Create Shareholder Value

    Our Macro Strategy to Create Shareholder VALUE GROW our Tissue Business > Lead private label in quality > Expand geographically > Diversify retail channel penetration Optimize Profitability of Paperboard and Tissue Businesses > Improve sales mix > Reduce costs > Continue to improve quality

  15. Slide 15: Successful execution of previously stated goals

    GOAL Optimize the Paperboard Business Successful execution of Previously StateD goals TIMEFRAME ongoing STATUS Permanent shutdown of two high cost tissue machines and restructuring at our Neenah, Wisconsin tissue facility Completed permanent closure of our Oklahoma City converting facility, as of Ma

  16. Slide 16: Clearwater Paper cross cycle financial model

    clearwater paper cross cycle FINANCIAL MODEL 1 Net sales for the twelve months ending December 31, 2016 and three months ending March 31, 2017 were $1,734.8M and $437.5M, respectively. 2 Non-GAAP measure – See Appendix for the definition and reconciliation to the most comparable GAAP measure. 2016 R

  17. Slide 17: 2017 Focus

    2017 FOCUS Pulp optimization at mills Increase operating equipment efficiencies Execute on our manufacturing network optimization plan 2017 FOCUS Reduce supply chain costs through further improvements in logistics optimization Complete warehouse automation project at Lewiston and Elwood facilities I

  18. Slide 18: Strategic investments expected to achieve Adjusted EBITDA margin target

    Strategic Investments expected to Achieve adjusted ebitda Margin Target (MILLIONS $) 2015 2016 2017-2018 FULL RUN-RATE EXPECTED1 STRATEGIC INVESTMENTS2 Capex CAPEX CAPEX ADJUSTED EBITDA Impact Pulp Optimization $29 $61 $58-$68 $30-$35 Warehouse Automation4,5 $12 $16 $4-$6 $20-$21 Paper Machine and C

  19. Slide 19: Strategic investment and operational improvement scorecard as of Q1'17

    Strategic investment and operational improvement scorecard as of Q1’17 Strategic plan announced in Q1’15, expected capex of $229-$2411 million Expected to yield a $98-$1282 million operating income increase by 20184 Expected to yield a $115-$145 million Adjusted EBITDA3 increase by 20184 Would yield

  20. Slide 20: Expected Adjusted EBITDA from strategic investments and operational improvements

    Expected Adjusted ebitda from strategic investments and operational improvements1, 2 Expected to yield a $115-$145 million Adjusted EBITDA increase over the $230M reset run rate1 In addition, assume an annual $10-15 million of margin pressure Implies $285-$335 million Adjusted EBITDA run rate in 201

  21. Slide 21: Shelby Expansion: $340 Million Paper Machine

    SHELBY EXPANSION: $340 MILLION PAPER MACHINE Install NTT Tissue Machine and Converting Equipment location Shelby, NC adjacent to current Tissue plant Capacity 70,000 Tons Cost $283 Million START PRODUCTION Q1-2019 Full SHIPMENT RUN-Rate Late 2020 WAREHOUSE CONSOLIDATION Improve operational efficienc

  22. Slide 22: Why Invest Now?

    Why INVEST Now? We need additional ultra-quality tissue capacity to keep pace with our existing customers’ growth and the capacity to add new customers We have limited availability of ultra-quality tissue today Demand for about half the capacity within our existing customer base Ultra-quality segmen

  23. Slide 23: Clearwater Paper's Value Proposition

    Clearwater Paper’s Value Proposition

  24. Slide 24: Balanced Capital Allocation

    Balanced Capital Allocation 2011-2016 Repurchased 34% of total shares outstanding from 2011 through 2016 Continued investment in the business while returning capital to investors Capital Allocation 2011-2016 2011–2016 Capex 32% TAD Expansion & Strategic Capex 36% Stock Repurchase 32% Cumulative Shar

  25. Slide 25: Clearwater Paper is a Leader Amongst its Peers in Value Creation

    Clearwater Paper Small-Cap Tissue1 Paperboard2 Large-Cap Consumer3 S&P 500 Kimberly Clark Clearwater Paper is a Leader Amongst its Peers in Value Creation Source: Bloomberg. Market data as of May 1, 2017 Note: Total Shareholder Return includes dividends reinvested and stock price performance. 1 Smal

  26. Slide 26: Which Has Led to Multiple Expansion Since the Spin

    ² Paperboard peers include International Paper, Graphic Packaging, Kapstone, MeadWestvaco, Packaging Corp of America, Sonoco and WestRock. MeadWestvaco is excluded following merger announcement with Rock-Tenn on January 26, 2015. ³ Large-cap consumer product peers include Kimberly-Clark and Procter

  27. Slide 27: Clearwater Paper's Outlook

    Ly CLEARWATER, PAPER, CLEARWATER PAPER’S OUTLOOK

  28. Slide 28: Q2'17 Outlook Reconciliation of Non-GAAP Financial Measures

    Q2’17 Outlook1 Reconciliation of Non-GAAP Financial Measures (Unaudited) 1 This information is based upon management’s current expectations and estimates, which are in part based on market and industry data. Many factors are outside the control of management, including particularly input costs for c

  29. Slide 29: Q2'17 Outlook Reconciliation of Non-GAAP Financial Measures

    Q2’17 Outlook1 Reconciliation of Non-GAAP Financial Measures (Unaudited) 1 This information is based upon management’s current expectations and estimates, which are in part based on market and industry data. Many factors are outside the control of management, including particularly input costs for c

  30. Slide 30: Q2'17 Outlook

    Q2’17 OUTLOOK1 1This information is based upon management’s current expectations and estimates, which are in part based on market and industry data. Many factors are outside the control of management, including particularly input costs for commodity products, and actual results may differ materially

  31. Slide 31: Appendix

    ty Sx zeal Tss: zi APPENDIX

  32. Slide 32: Definitions of Non-GAAP Measures

    Definitions of Non-GAAP Measures Clearwater Paper Definitions of Non-GAAP Measures EBITDA is a non-GAAP measure that Clearwater Paper management uses as a supplemental performance measure to evaluate the cash generating capacity of Clearwater Paper. The most directly comparable GAAP measure is net e

  33. Slide 33: Reconciliation of GAAP to Non-GAAP: EBITDA and Adjusted EBITDA

    Reconciliation of GAAP to Non-GAAP: Clearwater Paper EBITDA1 and Adjusted EBITDA1 ¹ Non-GAAP measure – See Appendix for the definition. 2 Interest expense, net for 2009, 2013, 2014 and 2016 includes debt retirement costs of $6.2, $17.1, $24.4 and $0.4 million respectively. ($ in millions) 2009 2010

  34. Slide 34: EBITDA & Adjusted EBITDA Reconciliation

    EBITDA & Adjusted EBITDA Reconciliation of Non-GAAP Financial Measures (Unaudited) 1 EBITDA is a non-GAAP measure that management uses as a supplemental performance measure. The most directly comparable GAAP measure is net earnings (loss). EBITDA is net earnings (loss) adjusted for net interest expe

  35. Slide 35: Segment EBITDA & Adjusted EBITDA Reconciliation

    Segment EBITDA & Adjusted EBITDA Reconciliation of Non-GAAP Financial Measures (Unaudited) 1 Segment EBITDA is a non-GAAP measure that management uses as a supplemental performance measure. The most directly comparable GAAP measure is segment operating income (loss). Segment EBITDA is segment operat

  36. Slide 36: Adjusted Gross Profit & Adjusted SG&A Reconciliation

    Adjusted Gross Profit & Adjusted SG&A Reconciliation of Non-GAAP Financial Measures (Unaudited) 1 Gross profit is defined as net sales minus cost of sales. 2 Adjusted gross profit and Adjusted selling, general and administrative expenses exclude the impact of the items listed that we do not believe

  37. Slide 37: Segment Adjusted Operating Income (Loss) Reconciliation

    Segment Adjusted Operating Income (Loss) Reconciliation of Non-GAAP Financial Measures (Unaudited) 1 Adjusted operating income (loss) excludes the impact of the items listed that we do not believe are indicative of our core operating performance.

  38. Slide 38: Adjusted Net Earnings & Adjusted Net Earnings per Diluted Common Share

    Adjusted Net Earnings & Adjusted Net Earnings per Diluted common share Reconciliation of Non-GAAP Financial Measures (Unaudited) 1 All non-tax items are tax effected at the expected annual rate for that period. 2 Adjusted net earnings and Adjusted net earnings per diluted common share exclude the im

  39. Slide 39: Key Segment Results – Pulp and Paperboard

    Key Segment Results – Pulp and Paperboard (Unaudited) 1 Non-GAAP measure – See Appendix for the definition and reconciliation to the most comparable GAAP measure. 2 Non-GAAP measure – Segment Adjusted EBITDA margin is defined as Segment Adjusted EBITDA divided by Segment net sales. 3 Results include

  40. Slide 40: Key Segment Results – Consumer Products

    Key Segment Results – Consumer Products (Unaudited) 1 Includes away-from-home (AFH), contract and parent roll tissue products. 2 Includes retail, AFH, and contract tissue case products. 3 Non-GAAP measure – See Appendix for the definition and reconciliation to the most comparable GAAP measure. 4 Non

  41. Slide 41: Reconciliation of GAAP to Non-GAAP: Strategic Investments

    Reconciliation of GAAP to Non-GAAP: Strategic investments1 (Unaudited) 1 Based on Q1’15 prices, input costs, and market and industry data. Many factors are outside the control of management, including particularly input costs for commodity products, and actual results may differ materially from the

  42. Slide 42: Reconciliation of GAAP to Non-GAAP: Strategic Investments

    Reconciliation of GAAP to Non-GAAP: Strategic investments1 (Unaudited) 1 Based on Q1’15 prices, input costs, and market and industry data. Many factors are outside the control of management, including particularly input costs for commodity products, and actual results may differ materially from the

  43. Slide 43: Reconciliation of GAAP to Non-GAAP: Shelby Expansion

    Reconciliation of GAAP to Non-GAAP: SHELBY EXPANSION1 (Unaudited) 1 Based on Q1’15 prices, input costs, and market and industry data. Many factors are outside the control of management, including particularly input costs for commodity products, and actual results may differ materially from the infor

  44. Slide 44: Major Maintenance Schedule

    Major Maintenance Schedule1 1 This information is based upon management’s expectations and estimates as of February 8, 2017. 2015 2016 2017 2018 2019 2020 2021 2022 Major Maintenance $ Millions $22 $18 $24-26 (F) $0 TBD TBD TBD TBD Lewiston Q1 Q3 Q3 Q1 Q3 Q1 Cypress Bend Q2 Q2 Q3 Q2

  45. Slide 45: 2017 Pulp and paperboard total maintenance

    2017 Pulp and paperboard total maintenance1 2017 Regular planned maintenance - $40 - $43 million 2017 Major maintenance (including indirect costs) $27 - $29 million 2017 Total maintenance $67 -$72 million 1 This information is based upon management’s expectations and estimates as of May 5, 2017.

  46. Slide 46: North American Tissue Projected Capacity Change

    North American Tissue Projected Capacity Change Source: RISI Company Mill/Location Conv/TAD Capacity Change Estimated Date Channel/Business/Products Announced New Capacity through 2019 Von Drehle Corporation Natchez, MS Conv 35,000 2016:Q1 Valmet Advantage NTT St. Croix Tissue (APP) Baileyville, ME

Clearwater Paper — Investor Presentation (May 2017) on 6ix